These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 2540905)
1. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
2. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line. Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971 [TBL] [Abstract][Full Text] [Related]
4. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE; Bepler G; Kubasch M; Havemann K Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327 [TBL] [Abstract][Full Text] [Related]
6. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
7. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030 [TBL] [Abstract][Full Text] [Related]
8. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397 [TBL] [Abstract][Full Text] [Related]
9. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Gazdar AF; Carney DN; Nau MM; Minna JD Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258 [TBL] [Abstract][Full Text] [Related]
10. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related]
11. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related]
12. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines. Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569 [TBL] [Abstract][Full Text] [Related]
13. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Johnson BE; Makuch RW; Simmons AD; Gazdar AF; Burch D; Cashell AW Cancer Res; 1988 Sep; 48(18):5163-6. PubMed ID: 2842046 [TBL] [Abstract][Full Text] [Related]
14. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. Johnson BE; Brennan JF; Ihde DC; Gazdar AF J Natl Cancer Inst Monogr; 1992; (13):39-43. PubMed ID: 1327035 [TBL] [Abstract][Full Text] [Related]
15. Expression of the L-myc gene is under positive control by short-lived proteins. Saksela K Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780 [TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F; Poupon MF; Le Chevalier T Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004 [TBL] [Abstract][Full Text] [Related]
19. myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Brennan J; O'Connor T; Makuch RW; Simmons AM; Russell E; Linnoila RI; Phelps RM; Gazdar AF; Ihde DC; Johnson BE Cancer Res; 1991 Mar; 51(6):1708-12. PubMed ID: 1847842 [TBL] [Abstract][Full Text] [Related]
20. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines. Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]